Comparing intraoperative parathyroid identification based on surgeon experience versus near infrared autofluorescence detection - A surgeon-blinded multi-centric study
Giju Thomas, Carmen C Solórzano, Naira Baregamian, Emmanuel A Mannoh, Rekha Gautam, Rebecca T Irlmeier, Fei Ye, Jon A Nelson, Samuel E Long, Paul G Gauger, Alexa Magner, Tyler Metcalf, Lawrence A Shirley, John E Phay, Anita Mahadevan-Jansen, Giju Thomas, Carmen C Solórzano, Naira Baregamian, Emmanuel A Mannoh, Rekha Gautam, Rebecca T Irlmeier, Fei Ye, Jon A Nelson, Samuel E Long, Paul G Gauger, Alexa Magner, Tyler Metcalf, Lawrence A Shirley, John E Phay, Anita Mahadevan-Jansen
Abstract
Background: Near infrared autofluorescence (NIRAF) detection has previously demonstrated significant potential for real-time parathyroid gland identification. However, the performance of a NIRAF detection device - PTeye® - remains to be evaluated relative to a surgeon's own ability to identify parathyroid glands.
Methods: Patients eligible for thyroidectomy and/or parathyroidectomy were enrolled under 6 endocrine surgeons at 3 high-volume institutions. Participating surgeons were categorized based on years of experience. All surgeons were blinded to output of PTeye® when identifying tissues. The surgeon's performance for parathyroid discrimination was then compared with PTeye®. Histology served as gold standard for excised specimens, while expert surgeon's opinion was used to validate in-situ tissues.
Results: PTeye® achieved 92.7% accuracy across 167 patients recruited. Junior surgeons (<5 years of experience) were found to have lower confidence in parathyroid identification and higher tissue misclassification rate per specimen when compared to PTeye® and senior surgeons (>10 years of experience).
Conclusions: NIRAF detection with PTeye® can be a valuable intraoperative adjunct technology to aid in parathyroid identification for surgeons.
Keywords: Near infrared autofluorescence; Parathyroid glands; Parathyroidectomy; Surgical guidance; Thyroidectomy.
Conflict of interest statement
DISCLOSURES
A. Mahadevan-Jansen, J. E. Phay and Vanderbilt University have a licensing agreement with AiBiomed (Santa Barbara, CA) for PTeye®. A. Mahadevan-Jansen is also an equity holder at AiBiomed. Other authors have no conflicts of interest to declare.
Copyright © 2021 Elsevier Inc. All rights reserved.
Figures
Source: PubMed